First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis. [electronic resource]
Producer: 20190522Description: 765-772 p. digitalISSN:- 1432-0851
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cohort Studies
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Humans
- Melanoma -- drug therapy
- Neoplasm Metastasis
- Nivolumab -- therapeutic use
- Programmed Cell Death 1 Receptor -- immunology
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Mas
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Retrospective Studies
- Signal Transduction
- Skin Neoplasms -- drug therapy
- Survival Analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.